Researchers develop ultra-high-performance method to analyze oxylipins
NDR contributed to the work that was published by Dr. Adriano Chaves-Filho and the Dr. Sayuri Miyamoto team. To profile oxylipins in...
top of page
Blog
- Aug 10
- 1 min
NDR starts clinical trial with TVALA
Neurodegenerative disease research is pleased to announce the progress of developing TVALA for the treatment of neuroinflammation in ALS....
22 views
- Feb 2
- 1 min
Innovate Indiana recognizes Dr. Chandler Walker for secretome work
Indiana University researcher Chandler Walker, Ph.D., developed a stem cell-based secretome therapy that influences both the central and...
27 views
- Jan 24
- 1 min
NDR publishes novel study
The preprint manuscript Assessment of levamisole HCl and thymosin α1 in two mouse models of amyotrophic lateral sclerosis by David R...
31 views
- Jan 11
- 2 min
Dr. Chandler Walker publishes CTMP data
NDR congratulates Dr. Chandler Walker, Associate Professor in the department of Biomedical Sciences and Comprehensive Care, Indiana...
15 views
- Dec 8, 2022
- 1 min
Congratulations to Dr. Susanne Petri and her team!
NDR would like to congratulate Dr. Susanne Petri and her research team on their recent paper Altered Immunomodulatory Responses in the...
20 views
- Nov 9, 2022
- 1 min
NDR awards Dr. Chandler Walker $1.1 Million for ALS Research
Dr. Chandler Walker, associate professor in the Department of Biomedical Sciences and Comprehensive Care at Indiana University School of ...
42 views
- Nov 7, 2022
- 1 min
Verge Genomics starts Phase I Human trial with VRG50635
San Francisco-based Verge Genomics has begun a phase 1 human trial for its ALS drug candidate, VRG50635, that was discovered by...
20 views
- Sep 29, 2022
- 1 min
Ghada Maged receives NDR student award
NDR is pleased to announce research support for Ghada Maged for an ALS biomarkers project. Ms. Maged is currently completing an M. Sc....
11 views
- Sep 22, 2022
- 1 min
Dr. Chandler Walker moves to final round of IU Idea to Startup Pitch Competition
Dr. Walkers business idea "Cell-based therapy for ALS" was selected for advancing to the IU Idea to Startup Pitch Competition finals....
11 views
- Sep 16, 2022
- 1 min
A Personal Message from Dr. Siddique
In this final installment, Dr. Siddique delivers a personal message.
14 views
- Sep 12, 2022
- 1 min
Second Video Installment
In this second installment, Dr. Siddique discusses the future of ALS research and its implications for researchers and patients. We hope...
11 views
- Sep 7, 2022
- 1 min
New Video Series
We're pleased to announce that Northwestern University-Feinberg School of Medicine has produced a three-part video series on ALS,...
16 views
- Aug 31, 2022
- 1 min
NDR's TVALA® Trademarked
The lead molecule under development by NDR for treating neuroinflammation is the retro-inverso thymopentin, TVALA®. The application for...
79 views
- Aug 17, 2022
- 1 min
Low-cost detection of ALS biomarkers
Dr. Mohtashim Shamsi, Southern Illinois University, finalized his 2-year project with NDR. Shamsi investigated the feasibility of using...
16 views
- Jun 6, 2022
- 1 min
Stealth BioTherapeutics investigates SBT-272 to treat mitochondrial dysfunction in ALS
SBT-272, in the pipeline at Stealth BioTherapeutics, is a new peptidomimetic being investigated as a potential therapy for...
10 views
- May 24, 2022
- 1 min
FDA approves oral edavarone to treat adults living with ALS
FDA has approved Radicava ORS (edaravone) oral suspension for the treatment of adults with amyotrophic lateral sclerosis (ALS). Radicava...
12 views
- May 9, 2022
- 1 min
Sayuri Miyamoto to present a poster at the Paris Redox 2022 World Conference
NDR is pleased to congratulate Dr. Sayuri Miyamoto and her co-workers Adriano Chaves-Filho, Rosangela Santos, Rodrigo Lima, Larissa...
15 views
- May 4, 2022
- 1 min
Cornerstone for ALS Researchers
We are pleased to announce that Dr. Steve Pelech, Kinexus Bioinformatics Corp, completed a long time goal with funding help from NDR....
27 views
- Apr 4, 2022
- 1 min
Research notes from Dr. Miyamoto
We are pleased to let you hear Dr. Sayuri Myiamoto present her preliminary work, listen to the video. There is a lot more to learn, and...
14 views
bottom of page